CBD Cigarettes Instead of Normal Cigarettes as Innovative Treatment for Schizophrenia

Psychiatric Hospital of the University of Basel

Status: Unknown

Conditions: Schizophrenia and Other Psychotic Disorders; Harm Reduction

Treatments: Other: CBD-Cigarettes

Study type: Interventional

Funder types: Other

Identifiers

NCT04700930

2018-01111

Details and patient eligibility

About

Interventional study using Cannabidiol containing cigarettes as replacement of usual cigarettes

Reduction of enforcement measures, improved acute treatment, harm reduction, and improvement of psychotic symptoms

Enrollment: 31 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of Schizophrenia or Related Disorders
• PANNS > 21,
• Tobacco-smokers
• inpatient status
• within age 18 - 65 years
• German-speaking

Exclusion criteria

• personality disorder
• non-smokers
• organic psychotic diseases
• breast feeding
• pregnancy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

31 participants in 2 patient groups

CBD

Experimental group

Description:

Patients receive CBD cigarettes additionally to standard psychiatric care including neuroleptic medication

Treatment:

Other: CBD-Cigarettes

Non-CBD

No Intervention group

Description:

Patients recieve standard psychiatric care including neuroleptic medication